Correction to: Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12 (Journal of Cancer Research and Clinical Oncology, (2020), 146, 12, (3359-3369), 10.1007/s00432-020-03316-5)

  • Ji Hyun Park
  • , Sang Hoon Chun
  • , Yun Gyoo Lee
  • , Hyun Chang
  • , Keun Wook Lee
  • , Hye Ryun Kim
  • , Seong Hoon Shin
  • , Ho Jung An
  • , Kyoung Eun Lee
  • , In Gyu Hwang
  • , Myung Ju Ahn
  • , Sung Bae Kim
  • , Bhumsuk Keam

Research output: Contribution to journalComment/debate

1 Scopus citations

Fingerprint

Dive into the research topics of 'Correction to: Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12 (Journal of Cancer Research and Clinical Oncology, (2020), 146, 12, (3359-3369), 10.1007/s00432-020-03316-5)'. Together they form a unique fingerprint.

Medicine and Dentistry